Latest Blogs

Jun 25, 2019
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Jun 25, 2019
"We are in a unique moment in terms of the pace of breakthroughs that are being made and the variety of places that breakthroughs are happening," writes Dr. Peter P. Yu.
Jun 25, 2019
We owe it to this vulnerable population to check our assumptions and deliver the highest-quality cancer care in a safe and welcoming environment.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Subscribe to this column

Julie Vose, MD, MBA, FASCO

Julie M. Vose, MD, MBA, FASCO, is the 2015-2016 President of ASCO. She is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center. She is also the Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center.

In addition to being ASCO President, Dr. Vose also serves on the Special Awards Selection and Health Disparities Committees. An ASCO member since 1991, Dr. Vose has served on the Board of Directors, Nominating Committee, Scientific Program Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board. She served as Chair of the Cancer Education Committee and Publications Committee. Follow Dr. Vose on Twitter at @DrJulieVose.

Oct 21, 2015
Dear ASCO Member: Over the past year the American Board of Internal Medicine (ABIM) has engaged with ASCO and other stakeholders to listen to the concerns of physicians and redesign their Maintenance of Certification (MOC) program. We have advocated for reform and the ABIM is responding.  The...
Sep 22, 2015
In the latest workforce study for oncology conducted by ASCO, approximately 30% of practicing oncologists were women. However, this number is expected to grow.
Aug 04, 2015
Clinical investigation forms the backbone and the history of medical oncology. Cancer clinical trials provide the evidence we need to demonstrate safety and efficacy before Food and Drug Administration (FDA) approval and evidence for our clinical treatment guidelines. However, it seems to be more...
Jul 10, 2015
As physicians who take care of patients with cancer, all of us worldwide have the same goals of cancer prevention, early detection and screening, improvement in the quality of cancer care, and accelerating research and new therapies. The question is, how can we accomplish these goals in a world...
Jun 01, 2015
In 1964, when the first seven physicians who founded ASCO met, I doubt they imagined what a successful Society they were forming. At that time, cancer treatments were just beginning to have some early successes with a few cytotoxic therapies, new radiation modalities, and improved surgical...

Pages